首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 901 毫秒
1.
利用反转录(RT)及套式PCR(N-PCR)方法扩增了中国猪瘟兔化弱毒株(C-株)兔脾组织毒主要保护性抗原E2(gp55)基因,成功地将其克隆并测定了核苷酸序列,与国内外已发表的猪瘟病毒(HCV)E2基因序列比较的结果是C-株兔脾毒与C-株细胞(SK6)毒、C-株疫苗(犊牛睾丸细胞,HCLV-C)毒、HCV-SM株(石门)毒、Brescia株(荷兰)毒、Alfort株(德国)毒的E2核苷酸序列同源性分别为98.87%、98.34%、94.58%、91.00%、80.78%;氨基酸同源性分别为98.95%、97.37%、94.22%、91.60%、89.23%。对C-株兔脾毒与C-株细胞毒、经典强毒及国内流行野毒E2上的A、B、C三个中和性抗原区的氨基酸组成进行了比较,其结果为C-株兔脾毒与C-株细胞毒的差异很小甚至没有差异,而与流行野毒及经典强毒在B、C区有较大的差异。我国经典强毒石门毒与国内80年代和90年代流行毒之间有明显的差异,表明我国猪瘟流行毒株发生了变化。  相似文献   

2.
以携带猪瘟病毒Thiverval株全长cDNA克隆的pAC/F101/T1-7载体质粒为模板,在体外转录病毒基因组RNA,并转染PK-15和BHK-21细胞,通过传代、RT-PCR、免疫过氧化物酶细胞单层试验鉴定,成功地在两种细胞中拯救出具有感染性的病毒粒子。同时,通过2种细胞转染效率的对比试验,成功建立了利用高转染效率的其它真核细胞作为病毒拯救的过渡细胞,然后再在猪肾细胞系上进行增殖的病毒拯救方式,极大提高了猪瘟病毒拯救的效率。  相似文献   

3.
猪瘟兔化弱毒疫苗株基因组的遗传变异分析   总被引:1,自引:0,他引:1  
参照已发表的猪瘟病毒基因组序列设计了9对引物,用RT-PCR从猪瘟兔化弱毒疫苗株细胞培养物中扩增得到了覆盖猪瘟病毒基因组全长的9个cDNA片段,将所得cDNA片段分别克隆至pMD18-T载体中,经测序和拼接后,获得了猪瘟兔化弱毒疫苗株基因组全序列。序列分析表明,猪瘟兔化弱毒疫苗株基因组全长12310个碱基,其5’非编码区(5'-NCR)和3'-NCR分别由373和239个碱基组成,在3’末端有富含T的碱基插入,其间为1个大的开放阅读框架,编码3898个氨基酸残基的多聚蛋白,与国内外已发表的另外7个猪瘟兔化弱毒疫苗株基因组全序列相比,核苷酸同源性为98.7%~99.9%,氨基酸同源性为98.6%~99.9%。基因组全序列比较显示,猪瘟兔化弱毒疫苗株基因组在遗传上相当稳定。  相似文献   

4.
急、慢性猪瘟病毒分离株和疫苗株E2基因的序列分析   总被引:9,自引:0,他引:9  
利用反转录(RT)及套式PCR(N-PCR)扩增并测定了6株具有不同表症近期甘肃省猪瘟流行野毒及C-株细胞疫苗毒的主要免疫原E2基因的核苷酸序列。序列分析比较结果表明,6株流行野毒与C-株疫苗毒的核苷酸同源性为82%-84%,流行野毒之间的核苷酸同源性在89%-99%之间,并且明显可分为二个组群,病毒株所属组群与其临床症状有一定的相关性。流行野毒与C-株毒在中和抗原决定簇上有部分氨基酸存在性质差异,可能影响C-株毒对流行野毒的中和滴度。  相似文献   

5.
猪瘟病毒流行株与疫苗株主要抗原编码基因差异研究   总被引:1,自引:0,他引:1  
从全国7个省市1200多份可疑猪瘟病料中分离出9个猪瘟病毒(HCV)野毒株,编号分别为HCV-01-09。将9株野毒分别通过PK15细胞分别通过PK15细胞传6代,测其毒价,并提纯做电镜观察,结果表明:毒价范围在10^2-10^7TCID50,电镜观察均可清晰地见到直径为25-70nm,略呈圆形的病毒颗粒,具有较完整的囊膜和纤突结构。从9株野毒中选取5株经猪瘟阴性猪各传3-4代,测其毒力、病原性、致死性,结果表明:各毒株在传代中其上述生物学特性上有变化和差别。用猪瘟兔化弱毒疫苗分别对这5株野毒做免疫保护相关性试验,结果证明:攻毒后的疫苗接种猪100%保护,而攻毒对照猪100%死亡,且对照猪在攻毒1周后便出现猪瘟野毒感染,而免疫猪在整个观察期均未见到野毒感染。用不同剂量的猪瘟兔化弱毒,表明猪瘟兔化弱毒不通过胎盘垂直感染仔猪。将猪瘟野毒株、石门系强毒株、兔化弱毒株及1982年分离的郑州野毒等毒株进行主要抗原编码基因差异研究,结果表明:猪瘟病毒可分2个基因组6个基因亚组,HCV-02、03、06、07等4个野毒株与国内的C株、石门强毒株、国外的C株、日本GPE株、ALD株、意大利Brescia株均属同一基困组,而HCV-08株及郑州株等2个野毒与法国的Alfor株同属另一个基因组。  相似文献   

6.
重组H5N3禽流感疫苗株在MDCK细胞中大规模增殖条件研究   总被引:2,自引:0,他引:2  
为研究通过反义遗传学技术构建的重组禽流感病毒rH5N3疫苗株在MDCK细胞中大规模增殖规律,确定最佳增殖条件,将rH5N3疫苗株分别在500mL和10L转瓶培养的MDCK细胞中进行增殖试验,检测不同接毒量以及接毒后不同时间里的血凝价,以确定病毒的增殖情况。结果表明,在确定的最佳病毒增殖条件下,该重组rH5N3疫苗株在500mL转瓶和10L转瓶中可获得大量增殖,病毒的最高血凝价均可达到1:1024。rH5N3疫苗株可以在MDCK细胞中大规模增殖,操作方法简便,成本低廉,该方法为禽流感细胞培养型疫苗的大规模生产奠定了基础。  相似文献   

7.
中国猪瘟兔化弱毒全基因组cDNA文库的构建和序列分析   总被引:1,自引:0,他引:1  
根据已发表的猪瘟病毒(CSFV)序列设计并合了26条覆盖全长基因组的套式和半套式PCR引物。应用RT-PCR、Nested PCR和Half-nested PCR技术从试验感染的兔脾中成功地扩增出了各相应的cDNA重叠片段,分别克隆和测序,构建了C株全基因组cDNA文库,采用DNAstar软件对全基因组的核苷酸和氨基酸序列进行了同源性比较分析。CSF C株全基因组cDNA文库的构建为进一步构建全长感染性cDNA奠定了基础。  相似文献   

8.
采用RT-PCR、Nested PCR和Half-nested PCR技术从试验感染兔脾组织的总RNA中得到了猪瘟病毒(CSFV)C株全长cDNA的3个待改造片段,分别克隆于pMD18-T载体后进行测序。用重组技术分别从前期构建的5′半长cDNA或3′半长cDNA中替换F1、F3和F51,构建成2个新的半长cDNA,进一步连接成新的全长cDNA,经测序证实全长cDNA中3个致死性突变位点均得到改正。初步鉴定证明该全长cDNA具有感染性。为猪瘟病毒C株反向遗传操作系统的建立奠定了基础。  相似文献   

9.
为了建立新城疫疫苗株Mukteswar株的反向遗传操作系统,根据Mukteswar株的基因序列设计了9对引物,扩增获得基因组片段,通过Overlap PCR和In-Fusion无缝克隆的技术,将9个片段拼接和插入至pACNR-T7中,获得了Mukteswar株全长cDNA克隆质粒pAC-Mukteswar。将其和3个辅助质粒(pVAX-NP、pVAX-P和pcDNA-L)共转染至预先感染了痘病毒vTF7-3的BHK-21细胞,成功拯救出重组病毒rMukteswar。对rMukteswar的生长曲线、最小致死剂量的平均致死时间(MDT)等生物学特性进行测定,结果显示rMukteswar具有和野生株相似的增殖特性和毒力。成功建立了新城疫疫苗株Mukteswar的反向遗传操作系统,为研发高效率表达外源病原体蛋白的新城疫载体疫苗奠定了基础。  相似文献   

10.
就瘟病毒属尤其是猪瘟病毒在宿主细胞中的增殖过程及遗传变异两个方面进行了介绍,其中增殖过程主要包括病毒吸附宿主细胞及其内化、基因复制表达、病毒粒子的装配及释放几个步骤,以期为研究瘟病毒在体内的增殖分布规律提供参考。  相似文献   

11.
以聚乙二醇(PEG,MW6000)沉淀法部分纯化的猪瘟兔化弱毒中国株(SFV-C)免疫BALB/C小鼠,取其脾脏制备脾细胞与SP2/0骨髓瘤细胞融合,经ELISA检测和有限稀释法克隆化筛选出9株对SFV特异的单克隆抗体(McAb)杂交瘤细胞。它们产生的McAb仅对SFV-C株发生特异性反应,而与SFV-S及BV DV Oregon株不发生反应.相加试验表明,9个McAb分别针对不同的抗原决定簇。所有的McAb均不具有沉淀反应特性。  相似文献   

12.
为有效鉴别猪瘟病毒强毒株(Shimen)与弱毒疫苗株(HCLV),根据GenBank上已发表的猪瘟病毒囊膜糖蛋白E2基因高度保守区设计一对特异性引物,在其跨越区内部有Shimen株独有的限制性内切酶Bgl Ⅱ酶切位点,采取酶切RT-PCR产物的方法鉴别Shimen株和疫苗株,同时对该方法的特异性和敏感性进行检测。结果表明,应用该方法从Shimen株和疫苗株中均能扩增出一条大小为750 bp的特异性片段,疫苗株的RT-PCR产物不能被Bgl Ⅱ酶切,Shimen株的RT-PCR产物则被酶切为大小分别为520和230 bp的两条带。此方法可扩增猪瘟病毒的E2基因保守片段,对病毒RNA的最小检出量为3.96×10-4 μg/mL。采用此方法检查了30例临床疑似猪瘟病料,结果3例感染猪瘟病毒强毒,21例为猪瘟弱毒疫苗株,其他为猪瘟阴性。  相似文献   

13.
河北省奶牛牛病毒性腹泻/粘膜病病毒的分离鉴定   总被引:5,自引:0,他引:5  
从河北省某规模化奶牛场牛病毒性腹泻/粘膜病(BVD/MD)疑似病例中采集病料,将处理好的病料接种MDBK细胞,盲传9代,得到了不产生细胞病变的病毒。琼脂扩散试验表明本病毒能与牛病毒性腹泻病毒(BVDV)OregonC24标准阳性血清反应,出现沉淀线;细胞培养物用BVD/MD荧光抗体染色检测,可见到荧光着染的特异性细胞,荧光颗粒出现于胞浆中。双抗体夹心ELISA检测病毒抗原结果BVDVOregonC24VP/N为3.141,分离毒P/N为3.012,P/N>2,与BVDVOregonC24V结果一致;电镜观察到圆形、直径为40~60nm,有囊膜,囊膜表面有突起的病毒粒子,与BVDV颗粒基本一致。经RT-CR检测,扩增出了唯一的315bp的目的条带,进一步证实为牛病毒性腹泻/粘膜病病毒。  相似文献   

14.
15.
为研究猪瘟病毒(CSFV)云南株(YN株)突变位点在致非典型性猪瘟中的作用,本研究在CSFV石门株全长感染性克隆的基础上,利用分子克隆技术,将CSFV YN株的1 510位~1 532位、2 471位~2 658位、3 152位~3 176位和11 785位~11 816位突变位点基因序列替换CSFV石门株的相应基因序列,构建出嵌合的CSFV感染性克隆质粒pAC-SM-YN。全基因测序鉴定后,体外转录得到病毒RNA,经脂质体转染PK-15细胞方法拯救出了嵌合病毒vSM-YN。经直接荧光染色、对突变位点RT-PCR以及ELISA检测表明拯救嵌合病毒vSM-YN传代稳定。本研究为研究CSFV结构蛋白、病毒致病机理、新型疫苗,尤其是非典型猪瘟的致病机理奠定了基础。  相似文献   

16.
猪瘟病毒贵州流行株E2基因原核表达及其免疫原性的研究   总被引:4,自引:1,他引:3  
本研究根据GenBank登录的猪瘟病毒Shimen和C株的E2基因序列设计1对特异引物,采集来自贵州的疑似猪瘟病死猪组织,提取总RNA,进行RT-PCR扩增,将扩增产物测序后进行核苷酸序列比较分析.并将RTPCR产物克隆到pMD18-T载体上,构建重组质粒pMD18-T-E2,经双酶切鉴定、核苷酸序列分析后,将E2基因亚克隆到pET-32a(+)原核表达载体上,成功构建猪瘟病毒E2基因原核表达质粒pET-32a-E2,将构建好的原核表达质粒pET-32a-E2转化至宿主菌BL21中,诱导表达目的蛋白,表达产物经SDS-PAGE电泳、Western blot分析,得到了约58 ku的条带,与预期大小相符,进一步提取、纯化目的蛋白,将目的蛋白加入弗氏佐剂免疫小鼠,免疫后采血检测抗体,结果显示目的蛋白能诱导小鼠产生一定抗体水平,该研究为猪瘟亚单位疫苗的研究奠定了基础.  相似文献   

17.
18.
【Objective】 This study was intend to obtain cathepsin L1(rFgCat L1) specific monoclonal antibody and construct the double antibody sandwich ELISA.【Method】 Five BALB/c mice were immunized with 1 mg/mL rFgCat L1 protein for four times.Mouse splenocytes were isolated and fused with SP2/0 cells to construct hybridoma cells.Strong positive hybridoma cell lines were screened, 1×106 cells were injected intraperitoneally per mouse to prepare monoclonal antibodies.Antibody titer and antigenic epitope were detected using ELISA method, antibody subtype and specificity were identified using Western blotting method.The double antibody sandwich ELISA was constructed by combining the anti-rFgCat L1 polyclonal antibody, and its sensitivity and specificity were tested.The positive and negative critical value was screened by 20 negative sera with positive control, and the constructed double antibody sandwich ELISA was verified by 47 goat positive sera and 47 dairy cow positive sera.【Result】 After immunization, the antibody titers in serum of 4 mice were all more than 104.After isolated mouse with the highest immune response spleen cells were fused with SP2/0 cells total of 8 of them were positive cell lines were obtained after selective culture.5D5 and 7G6 were identified as strong positive strains with stable antibody secretion.After multiple subcloning screens and subcultures, the antibodies secreted in the cell supernatant were stable, with titers of 29 and 210 respectively, with ascites titers of 107 and 108.Western blotting and antibody subtype identification kits identified that the two antibodies were IgG1 type and the light chain was kappa type, both of which could specifically bind FgESP.According to the same antigen site was recognized by the two kinds of antibodies, the antigen titer of the two monoclonal antibodies were comparied, 7G6 was used as the coating antibody, and anti-rFgCat L1 was used as the enzyme-labeled secondary antibody.The optimized condition of method was that 7G6 was coated at a concentration of 2 μg/mL, the dilution concentration of anti-rFgCat L1 polyclonal antibody was 25 μg/mL, the dilution of Don-HRP-conjugated was 1∶4 000, 5% skimmed milk powder was selected as the blocking solution and the color development time was 25 min.The method was proved that could recognize the lowest antigen concentration of 0.625 μg/mL, also could specifically recognize antigen of Fasciola fasciatus.The constructed sandwich ELISA method was used for antigen detection of 47 dairy cow positive serum and 47 goat positive serum infective samples kept in the laboratory and the positive antigen rate were 72.3% and 78.7%, respectively.【Conclusion】 Anti-rFgCat L1 monoclonal antibody was successfully prepared and the double-sheet sandwich ELISA method for fascioliasis was constructed, which provided a good theoretical basis and material basis for the development of low-cost and rapid diagnostic kits.  相似文献   

19.
The purpose of this investigation was to characterize the shedding pattern of feline leukemia virus (FeLV) RNA in saliva, and to correlate it with the proviral load in whole blood, viral load in plasma, levels of p27 in saliva and plasma, the isolation of infectious FeLV from saliva, and the titers of FeLV-specific antibodies of the IgG and IgA isotypes. We evaluated 24 experimentally FeLV-infected cats for these parameters using real-time RT-PCR and PCR, cell culture assay and sandwich ELISA. We observed that shedding of viral RNA in saliva was a consistent feature in viremic cats. Latently FeLV-infected cats, displaying a very low proviral load, did not shed infectious virus in saliva, but occasionally shed viral RNA. Consequently, salivary shedding of FeLV RNA may not necessarily indicate a transmission potential for susceptible cats. This study also confirmed previous results from our laboratory, showing that a negative result for p27 in plasma, or for viral RNA in plasma or saliva does not exclude FeLV infection, considering that blood cells from those cats contained provirus. We also showed that FeLV RNA and DNA were stable for more than 64 days in saliva samples stored at room temperature. We conclude that the detection of FeLV RNA in saliva may be a useful indicator of viremia, and that the detection of salivary viral RNA by RT-PCR could become a reliable tool for the diagnosis of FeLV infection, which is facilitated by the low invasive method of collection of the samples.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号